Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Enzyme Immunoassay Sector?
The market size for enzyme immunoassay has seen rapid expansion in the last few years. This upward trend is forecasted to continue, escalating from $20.01 billion in 2024 to $21.50 billion in 2025, representing a CAGR of 7.4%. Factors contributing to this historic boom include the increasing incidence of infectious diseases, the broadening of blood screening initiatives, an enhanced lab infrastructure, rising application in food safety examinations, and a surge in demand for veterinary diagnostic services.
Expansion of the enzyme immunoassay industry, currently anticipated to hit $28.37 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.2%, is predicted to be robust over the coming years. This growth anticipation for the forecasted period could be associated with disease management initiatives led by the government and NGOs, the detection of autoimmune diseases, increasing usage of point-of-care testing, surging demands in oncology for companion diagnostics, and an aging population. Emerging trends during the forecast period comprise upgrades in microplate readers and reagents technology, brand-new diagnostic methodologies, manufacture of environmentally friendly reagents, the integration of Artificial Intelligence and automation into immunoassays, along with collaborations and strategic alliances.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp
What Forces Are Driving The Growth Of The Enzyme Immunoassay Market?
The escalating problem of infectious diseases is predicted to fuel the expansion of the enzyme immunoassay market in the future. These diseases, caused by damaging microorganisms including bacteria, viruses, fungi, or parasites, can be transmitted among humans. As antimicrobial resistance makes it harder to treat typical infections, the problem of these diseases increases, resulting in extended sickness, augmented medical expenses, and higher death rates. Enzyme immunoassays are highly beneficial in detecting infectious diseases since they allow a precise and sensitive detection of antigens or antibodies in samples from patients, thus enabling early detection, efficient monitoring, and prompt treatment for infections like HIV, hepatitis, and influenza. For example, as per the Minnesota Department of Health, a government agency based in the US, the percentage of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, evidencing a significant surge in this group’s proportion of total cases. Thus, the escalating problem of infectious diseases is contributing to the expansion of the enzyme immunoassay market.
How Is The Enzyme Immunoassay Industry Segmented Across Key Parameters?
The enzyme immunoassay market covered in this report is segmented –
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses
Subsegments:
1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers
2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training
What Notable Trends Are Shaping The Direction Of The Enzyme Immunoassay Market?
Leading firms in the enzyme immunoassay market are prioritizing the development of novel EIA solutions, including fully automated enzyme immunoassays. These solutions aim to enhance diagnostic precision, minimize human errors, and streamline operations in clinical laboratories. Fully automated enzyme immunoassays involve diagnostic procedures that are carried out entirely by automated methods, thereby improving the swiftness and precision of lab results, and ensuring uniformity across results. For example, in July 2024, Fujirebio Holdings Inc., an in vitro diagnostics firm based in Japan, introduced its fully automated Lumipulse G GFAP assay intended solely for research purposes, broadening its offerings in the neuro-biomarker segment. This research-use-only chemiluminescent enzyme immunoassay measures the glial fibrillary acidic protein (GFAP), found in human plasma and serum, using the LUMIPULSE G platform, delivering accurate results in only 35 minutes. This assay provides a marking for astrocytic conditions like multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injuries. This assay further complements Fujirebio’s growing neuro range, which already boasts of NfL, pTau217, and sTREM2, offering a comprehensive neurodegenerative disease profiling within a unified automated system.
Which Companies Currently Dominate The Competitive Landscape In The Enzyme Immunoassay Industry?
Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report
Which Geographic Regions Are Driving Demand In The Enzyme Immunoassay Market?
North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
